title: On-demand treatment in persons with severe haemophilia.
abstract: There are two main modes of replacement therapy for haemophilia patients: either to stop bleeding (on-demand) or regular infusions of clotting factor to prevent bleeds (prophylaxis). Fifty yr of clinical experience have provided evidence of the superiority of prophylaxis by showing a reduction in bleeds and development of arthropathy. Prophylaxis has been described extensively in terms of efficacy and health-economic aspects; however, on-demand treatment has received less attention. The aim of this study was to critically review the published literature on PubMed and discuss potential gaps of knowledge in on-demand treatment in persons with severe haemophilia without inhibitors by focusing on two key aspects: how on-demand treatment is provided and what outcome measures have been reported. We identified 134 papers of which 112 were excluded. Of the remaining 22 papers, 16 were comparative studies between prophylaxis and on-demand treatment and six were descriptions of on-demand treatment. The results showed limited reporting on data related to the key aspects of treatment on-demand. Early studies looked at degrees of joint bleeds and different treatment regimens in finding the optimal dose. However, from the late 1980s, there was almost no research into on-demand therapy except efficacy and safety studies of new rFVIII products and studies to prove superiority of prophylaxis over treatment on-demand. The success of on-demand therapy may depend on several factors, for example time to initial dose after a bleed and duration of treatment. Data on these key factors are limited and highlight the necessity of research to optimise replacement therapy.
authors: Faculty of Medicine, Vilnius University, Vilnius, Lithuania; Centre for Pediatric Hematology/Oncology, Children's Hospital, Affiliate of Vilnius University Hospital Santariskiu Klinikos, Vilnius, Lithuania.
authors: Sonata
authors: S
authors: Saulyte Trakymiene
authors: Katarina
authors: K
authors: Steen Carlsson
mesh_terms: D005164:Factor IX / Q000008:administration & dosage*; D005169:Factor VIII / Q000008:administration & dosage*; D006467:Hemophilia A / Q000150:complications* / Q000175:diagnosis; D002836:Hemophilia B / Q000150:complications* / Q000175:diagnosis; D006470:Hemorrhage / Q000188:drug therapy* / Q000209:etiology* / Q000517:prevention & control; D006801:Humans; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D005169:Factor VIII; D005164:Factor IX
keywords: haemophilia; literature review; on-demand treatment; prophylaxis